David P. Richman

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

Multicentre Study, Pharmacology, Medicine +3

Mechanical Model of Brain Convolutional Development

David P. Richman, R. Malcolm Stewart, John W. Hutchinson et al. · Science · 1975 · 573 citations

Engineering, Developmental Cognitive Neuroscience, Brain Development +17

An international, phase III, randomized trial of mycophenolate mofetil in myasthenia gravis

Donald B. Sanders, I. K. Hart, Renato Mantegazza et al. · Neurology · 2008 · 308 citations

A Genome-Wide Association Study of Myasthenia Gravis

Alan E. Renton, Hannah A. Pliner, Carlo Provenzano et al. · JAMA Neurology · 2015 · 214 citations · Full text

2',3'‐Dideoxycytidine (ddC) toxic neuropathy

A. R. Berger, Joseph C. Arezzo, Herbert H. Schaumburg et al. · Neurology · 1993 · 157 citations